Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on June 29, 2026

6 hours ago

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Indeterminate GlobeNewswire

6 hours ago

Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen

Indeterminate GlobeNewswire

7 hours ago

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Indeterminate GlobeNewswire

7 hours ago

Zymeworks to Acquire Theravance Biopharma, Inc.

Indeterminate GlobeNewswire

8 hours ago

Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity

Indeterminate GlobeNewswire

8 hours ago

ITM, Helmholtz Munich and the University of Münster Announce Updated Preliminary Phase 1 Data with ITM-31 in Glioblastoma Patients

Indeterminate GlobeNewswire

9 hours ago

TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation

Indeterminate GlobeNewswire

10 hours ago

Aplagon Appoints Carl Lindgren as Board Chair to Guide Later Stage Clinical and Corporate Development

Indeterminate GlobeNewswire

10 hours ago

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

Indeterminate GlobeNewswire

11 hours ago

AB Science annonce l’achèvement de l’étape 3 de la phase 1, évaluant la combinaison d’AB8939 et du vénétoclax dans le traitement de la LMA réfractaire ou en rechute

Indeterminate GlobeNewswire

11 hours ago

AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML

Indeterminate GlobeNewswire

12 hours ago

Bavarian Nordics chikungunyavaccine er blevet godkendt af de canadiske lægemiddelmyndigheder

Indeterminate GlobeNewswire

12 hours ago

Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine

Indeterminate GlobeNewswire

12 hours ago

Arcera Life Sciences and Daewoong Expand Strategic Partnership to Bring Enavogliflozin to the Middle East

Indeterminate GlobeNewswire